Yangxin Li
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 2%
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Muscle Physiology and Disorders
Papers in
-
- Extracellular vesicles in disease 15
- Muscle Physiology and Disorders 10
- Circular RNAs in diseases 7
- RNA Interference and Gene Delivery 6
- Pluripotent Stem Cells Research 6
-
- MicroRNA in disease regulation 14
- Co-authors
- Yao‐Hua Song (26 shared papers)Patrice Delafontaine (9 shared papers)Yong‐Jian Geng (17 shared papers)Xiyong Yu (16 shared papers)Chun Liang (12 shared papers)Xi‐Yong Yu (14 shared papers)Bin Liu (12 shared papers)Xiangbin Pan (15 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (9 papers)Advances in experimental medicine and biology (3 papers)Brain Research (3 papers)Theranostics (3 papers)Signal Transduction and Targeted Therapy (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yangxin Li
88 papers receiving 5.1k citations
Yangxin Li's Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 1.2k
- Molecular Biology 3.0k
- Genetics 392
- Endocrinology, Diabetes and Metabolism 440
- Aging 49
Countries citing papers authored by Yangxin Li
This map shows the geographic impact of Yangxin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangxin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangxin Li more than expected).
Fields of papers citing papers by Yangxin Li
This network shows the impact of papers produced by Yangxin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangxin Li. The network helps show where Yangxin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yangxin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 454 | |
| 2 | 2005 | 290 | |
| 3 | 2017 | 252 | |
| 4 | 2019 | 232 | |
| 5 | 2007 | 229 | |
| 6 | 2021 | 185 | |
| 7 | 2016 | 183 | |
| 8 | Ribosome biogenesis in disease: new players and therapeutic targets Hit paper breakdown → | 2023 | 168 |
| 9 | 2009 | 167 | |
| 10 | 2007 | 162 | |
| 11 | 2020 | 161 | |
| 12 | 2018 | 152 | |
| 13 | 2008 | 148 | |
| 14 | 2016 | 145 | |
| 15 | 2009 | 131 | |
| 16 | 2019 | 123 | |
| 17 | 2019 | 100 | |
| 18 | 1999 | 96 | |
| 19 | 2019 | 78 | |
| 20 | 2003 | 76 |
About Yangxin Li
Yangxin Li is a scholar working on Molecular Biology, Cancer Research, Surgery, Immunology and Genetics, having authored 91 papers that have together received 5.1k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (15 papers), MicroRNA in disease regulation (14 papers), Muscle Physiology and Disorders (10 papers), Tissue Engineering and Regenerative Medicine (8 papers), Circular RNAs in diseases (7 papers), RNA Interference and Gene Delivery (6 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Pluripotent Stem Cells Research (6 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (3.0k citations), Genetics (392 citations), Endocrinology, Diabetes and Metabolism (440 citations) and Aging (49 citations). Yangxin Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yao‐Hua Song, Patrice Delafontaine, Yong‐Jian Geng, Xiyong Yu, Chun Liang, Xi‐Yong Yu, Bin Liu, Xiangbin Pan, Yanli Wang and Nadia Rosenthal. Their work appears in journals such as Biochemical and Biophysical Research Communications, Advances in experimental medicine and biology, Brain Research, Theranostics and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.